Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-EGFR drug

• 收藏
• 分享

专利权人:

CROWN BIOSCIENCE; INC. (Taicang)

发明人:

Henry Qixiang Li,Mengmeng Yang

申请号：

US14418684

公开号：

US09921222B2

申请日:

2013.07.31

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention provides methods for the treatment of lung cancer patients, especially NSCLC with SCC or PLC using a drug against EGFR, such as an anti-EGFR antibody treatment, e.g., cetuximab. In addition, the present invention provides methods for identification or selection of lung cancer patients for the treatment with a drug against EGFR, such as an anti-EGFR antibody treatment, e.g., cetuximab based on histological determinations.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/